Literature DB >> 24138596

Plaque At RISK (PARISK): prospective multicenter study to improve diagnosis of high-risk carotid plaques.

M T B Truijman1, M E Kooi, A C van Dijk, A A J de Rotte, A G van der Kolk, M I Liem, F H B M Schreuder, E Boersma, W H Mess, R J van Oostenbrugge, P J Koudstaal, L J Kappelle, P J Nederkoorn, A J Nederveen, J Hendrikse, A F W van der Steen, M J A P Daemen, A van der Lugt.   

Abstract

BACKGROUND: Patients with symptomatic carotid artery stenosis are at high risk for recurrent stroke. To date, the decision to perform carotid endarterectomy in patients with a recent cerebrovascular event is mainly based on degree of stenosis of the ipsilateral carotid artery. However, additional atherosclerotic plaque characteristics might be better predictors of stroke, allowing for more precise selection of patients for carotid endarterectomy. AIMS AND HYPOTHESIS: We investigate the hypothesis that the assessment of carotid plaque characteristics with magnetic resonance imaging, multidetector-row computed tomography angiography, ultrasonography, and transcranial Doppler, either alone or in combination, may improve identification of a subgroup of patients with < 70% carotid artery stenosis with an increased risk of recurrent stroke.
METHODS: The Plaque At RISK (PARISK) study is a prospective multicenter cohort study of patients with recent (<3 months) neurological symptoms due to ischemia in the territory of the carotid artery and < 70% ipsilateral carotid artery stenosis who are not scheduled for carotid endarterectomy or stenting. At baseline, 300 patients will undergo magnetic resonance imaging, multidetector-row computed tomography angiography, and ultrasonography examination of the carotid arteries. In addition, magnetic resonance imaging of the brain, ambulatory transcranial Doppler recording of the middle cerebral artery and blood withdrawal will be performed. After two-years, imaging will be repeated in 150 patients. All patients undergo a follow-up brain magnetic resonance imaging, and there will be regular clinical follow-up until the end of the study. STUDY OUTCOMES: The combined primary end-point contains ipsilateral recurrent ischemic stroke or transient ischemic attack or new ipsilateral ischemic brain lesions on follow-up brain magnetic resonance imaging.
© 2013 The Authors. International Journal of Stroke © 2013 World Stroke Organization.

Entities:  

Keywords:  CT; MRI; atherosclerosis; prospective; stroke; ultrasound

Mesh:

Year:  2013        PMID: 24138596     DOI: 10.1111/ijs.12167

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  24 in total

Review 1.  Secondary Stroke Prevention: Improving Diagnosis and Management with Newer Technologies.

Authors:  Yahia Z Imam; Atlantic D'Souza; Rayaz A Malik; Ashfaq Shuaib
Journal:  Transl Stroke Res       Date:  2016-09-02       Impact factor: 6.829

2.  The Risk of Stroke and TIA in Nonstenotic Carotid Plaques: A Systematic Review and Meta-Analysis.

Authors:  N Singh; M Marko; J M Ospel; M Goyal; M Almekhlafi
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-09       Impact factor: 3.825

3.  Ischemic Stroke Patients Demonstrate Increased Carotid Plaque Microvasculature Compared to (Ocular) Transient Ischemic Attack Patients.

Authors:  Raf H M van Hoof; Floris H B M Schreuder; Patty Nelemans; Martine T B Truijman; Narender P van Orshoven; Tobien H Schreuder; Werner H Mess; Sylvia Heeneman; Robert J van Oostenbrugge; Joachim E Wildberger; M Eline Kooi
Journal:  Cerebrovasc Dis       Date:  2017-09-26       Impact factor: 2.762

4.  Proximal Region of Carotid Atherosclerotic Plaque Shows More Intraplaque Hemorrhage: The Plaque at Risk Study.

Authors:  G A J C Crombag; M Aizaz; F H B M Schreuder; F Benali; D H K van Dam-Nolen; M I Liem; C Lucci; A F van der Steen; M J A P Daemen; W H Mess; A van der Lugt; P J Nederkoorn; J Hendrikse; P A M Hofman; R J van Oostenbrugge; J E Wildberger; M E Kooi
Journal:  AJNR Am J Neuroradiol       Date:  2022-02       Impact factor: 3.825

5.  CT angiography-based radiomics as a tool for carotid plaque characterization: a pilot study.

Authors:  Savino Cilla; Gabriella Macchia; Jacopo Lenkowicz; Elena H Tran; Antonio Pierro; Lella Petrella; Mara Fanelli; Celestino Sardu; Alessia Re; Luca Boldrini; Luca Indovina; Carlo Maria De Filippo; Eugenio Caradonna; Francesco Deodato; Massimo Massetti; Vincenzo Valentini; Pietro Modugno
Journal:  Radiol Med       Date:  2022-06-09       Impact factor: 6.313

6.  Intraplaque Hemorrhage and the Plaque Surface in Carotid Atherosclerosis: The Plaque At RISK Study (PARISK).

Authors:  A C van Dijk; M T B Truijman; B Hussain; T Zadi; G Saiedie; A A J de Rotte; M I Liem; A F W van der Steen; M J A P Daemen; P J Koudstaal; P J Nederkoorn; J Hendrikse; M E Kooi; A van der Lugt
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

7.  Longitudinal assessment of carotid atherosclerosis after Radiation Therapy using Computed Tomography: A case control Study.

Authors:  Michele Anzidei; Jasjit S Suri; Luca Saba; Roberto Sanfilippo; Giancarlo Laddeo; Roberto Montisci; Mario Piga; Giovanni Maria Argiolas; Eytan Raz
Journal:  Eur Radiol       Date:  2015-09-25       Impact factor: 5.315

Review 8.  Carotid revascularization: risks and benefits.

Authors:  Marlene O'Brien; Ankur Chandra
Journal:  Vasc Health Risk Manag       Date:  2014-07-07

9.  A computer-simulation study on the effects of MRI voxel dimensions on carotid plaque lipid-core and fibrous cap segmentation and stress modeling.

Authors:  Harm A Nieuwstadt; Zaid A M Kassar; Aad van der Lugt; Marcel Breeuwer; Anton F W van der Steen; Jolanda J Wentzel; Frank J H Gijsen
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

10.  Plaque Composition as a Predictor of Plaque Ulceration in Carotid Artery Atherosclerosis: The Plaque At RISK Study.

Authors:  K Dilba; D H K van Dam-Nolen; A C van Dijk; M Kassem; A F W van der Steen; P J Koudstaal; P J Nederkoorn; J Hendrikse; M E Kooi; J J Wentzel; A van der Lugt
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-19       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.